Assignee
DASMAN DIABETES INST
KW·6 granted patents·3 pending applications·2 citations·filing 2019–2025
Top patents by PatentIndex Score
9 records- 0167US10844383B1Microrna dyslipidemia inhibitorDASMAN DIABETES INST·Filed 2019·Granted Nov 24, 2020·1 cites·9 claims
- 0266US10731219B1Method for preventing progression to metabolic syndromeDASMAN DIABETES INST·Filed 2019·Granted Aug 4, 2020·1 cites·5 claims
- 0354US2023245740A1Web-based pharmacogenomics toolDASMAN DIABETES INST·Filed 2022·Application pending·0 cites
- 0450US12502416B1PAM3CSK4 injection for the prevention and management of MASLDDASMAN DIABETES INST·Filed 2025·Granted Dec 23, 2025·0 cites·16 claims
- 0548US11098095B1Methods of inhibiting MMP-9DASMAN DIABETES INST·Filed 2020·Granted Aug 24, 2021·0 cites·7 claims
- 0647US11058710B1MicroRNA ANGPTL3 inhibitorDASMAN DIABETES INST·Filed 2020·Granted Jul 13, 2021·0 cites·19 claims
- 0740US11560595B2Method for preventing progression to type II DiabetesDASMAN DIABETES INST·Filed 2019·Granted Jan 24, 2023·0 cites·9 claims
- 0838US2022023231A1Method of treating postprandial inflammation and preventing weight gainDASMAN DIABETES INST·Filed 2021·Application pending·0 cites
- 0932US2021244689A1Method of treating postprandial inflammationDASMAN DIABETES INST·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when DASMAN DIABETES INST files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →